Feed/Companies/GlycoEra

GlycoEra

As of 14 Oct 2026, GlycoEra has raised $130M across 1 verified round on record; latest: $130 million Series B led by Novo Holdings, announced 27 May 2025.

BUILT ON

Visit site

Biologics aimed at precision immunology, targeting and degrading specific proteins associated with autoimmune diseases for improved patient outcomes.

glycoera.comWädenswil, Switzerland

LATEST ROUND

Series B

$130M · 2025-05-27

RAISED ON RECORD · USD

$130M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 2 publishers

Rounds

[ 1 ]

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$130M	2025-05-27	Novo Holdings	No recent discussion
2 sources [ VERIFIED ] read against 2 sources [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: glycoera.com, globenewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage

GlycoEra

Rounds

Company

Rounds

Sources

Profile

Investors

GlycoEra

Rounds

Profile

Sources

Series B$130M2025-05-272 sources

Investors

Series B$130M2025-05-2711 investors